FIELD: chemistry.
SUBSTANCE: risk group is made first. Urine samples of athletes undergo high performance liquid chromatography coupled with tandem mass spectrometry. Content of indirect biochemical markers - L-arginine, asymmetrical dimethylarginine, symmetrical dimethylarginine and citrulline is determined. If content of the defined products in the sample is not within 0.9-1.2 of the averaged standard, the athlete is removed from the risk group. If content of the said products is at least greater than 1.5 times the averaged standard, the athlete is included in the risk group. The urine sample of the said athlete is subjected to isoelectric fixation, double blotting and chemoluminescent analysis for exogenous erythropoietin.
EFFECT: method cuts the time for testing a group of athletes for doping and expenses for carrying out analysis.
3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING USE OF CORTICOTROPINS FOR DURING DOPING TESTS IN ATHLETES | 2008 |
|
RU2384846C1 |
| METHOD FOR IDENTIFICATION AND CLASSIFICATION OF 3-OXOSTEROIDS AND THEIR METABOLITES IN DOPING TEST OF SPORTSMEN | 2010 |
|
RU2452967C2 |
| METHOD OF DETECTING XENOBIOTICS IN HUMAN URINE DURING DOPING TESTS | 2008 |
|
RU2390773C2 |
| METHOD TO DETECT DOPING IN HORSES | 2011 |
|
RU2489719C2 |
| METHOD FOR RETROSPECTIVE XENOBIOTIC DETECTION ACCOMPANYING SPORTSMEN DOPING CONTROL PROCEDURE | 2011 |
|
RU2478207C1 |
| METHOD FOR STEROID PROFILING IN DOPE TEST OF SPORTSMEN | 2011 |
|
RU2467331C1 |
| METHOD OF DETECTING CONJUGATED XENOBIOTICS DURING DOPING TESTS IN ATHLETES | 2011 |
|
RU2451936C1 |
| ANTI-DOPING METHOD FOR INCREASING SPORTSMAN'S PERFORMANCE WITH USING HALOGEN-CONTAINING MINERAL WATER LAZAREVSKAYA TSELEBNAYA | 2013 |
|
RU2532346C1 |
| METHOD OF DETERMINING HOMOLOGOUS BLOOD TRANSFUSION IN DOPING CONTROL OF ATHLETES | 2011 |
|
RU2470304C2 |
| COMPOSITION POSSESSING ENDOTHELIAL PROTECTIVE, VASODILATING AND ANGIOPROTECTIVE EFFECT | 2011 |
|
RU2464019C1 |
